Capstone Therapeutics (CAPS)

Add to Watchlists
Create an Alert
0.224 +0.00  +1.36% OTC Markets Aug 28, 20:00 Delayed 15m USD
View Full Chart
CAPS Price Chart
View All Performance Charts

CAPS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Capstone Therapeutics is down 29.02% over the last year vs S&P 500 Total Return up 1.66%, Agenus up 130.5%, and Anika Therapeutics down 14.20%.


CAPS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website:
  • HQ Country: United States
  • HQ State/Province: Arizona
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: June 30, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Capstone Therapeutics Corp is a biotechnology company engaged in developing a pipeline of novel peptides and other molecules aimed at helping patients with under-served medical conditions.

CAPS Excel Add-In Codes

  • Name: =YCI("CAPS","name")
  • Description: =YCI("CAPS","description")
  • Sector: =YCI("CAPS","sector")
  • Industry: =YCI("CAPS","industry")
  • Est. Current Fiscal Year End: =YCI("CAPS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.